Devin Schellenberg
M.D., University of British Columbia,
2001 Fellow of the Royal College of Physicians and Surgeons of Canada (Radiation Oncology) - 2006
Research
My research interests relate to implementing emerging technologies into the planning and delivery of radiation therapy. I am interested in understanding how PET, cone beam CT and 4D-CT can improve external beam radiation and how novel radio-conjugates may be used for both PET imaging and therapeutic treatment. In the lab, I am working with Dr. Graves, studying tumor hypoxia and non-invasive imaging methods in both tissue culture and mouse models. In the clinic, I am evaluating PET imaging in pancreatic cancer and studying whether FLT (18F-Fluorothymidine) is more accurate than FDG (Fluoro-deoxy-glucose) for tumor delineation. I am also fortunate enough to be a part of several prospective trials evaluating stereotactic body radiation therapy (SBRT) for the treatment of lung tumors, pancreas tumors and liver metastases.
Publications
- Schellenberg D. Nichol A. Marlowe C. Duzenli C. Weir L. Olivotto I. The use of fiducial markers and real-time kilovoltage verification for partial breast irradiation. Canadian Journal of Medical Radiation Technology. 38(1)-in press.
- Keyes M. Schellenberg D. Moravan V. Mckenzie M. Agranovich A. Pickles T. Wu J. Liu M. Bucci J. And Morris WJ. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve? International Journal of Radiation Oncology, Biology, Physics. 64(3): 825-34, 2006.
- Schellenberg D. Pare PD. Weir TD. Spinelli JJ. Walker BA. Sandford AJ. Vitamin D binding protein variants and the risk of COPD. American Journal of Respiratory & Critical Care Medicine. 157(3 Pt 1):957-61, 1998.
